Xiangxue Pharmaceutical (300147.SZ) released its semi-annual report for 2024, with a revenue of 1.097 billion yuan...
According to the Smart Finance app, Xiangxue Pharmaceutical (300147.SZ) released its semi-annual report for 2024, with a revenue of 1.097 billion yuan, a year-on-year decrease of 8.72%. The net loss attributable to shareholders of the listed company was 0.135 billion yuan, with an expanded loss. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.108 billion yuan, with an expanded loss. The basic loss per share was 0.2 yuan/share.